Aortic stent grafts

Endurant™ II and Endurant™ IIs stent graft system

View the Endurant™ IIs stent graft and delivery system.View the Endurant™ IIs stent graft and delivery system.
No Image Available

Aortic stent grafts

Endurant™ II and Endurant™ IIs stent graft system

Endurant™ stent graft system is designed to treat abdominal aortic aneurysms (AAA) using a minimally invasive endovascular aneurysm repair (EVAR).

Ordering information
Contact a representative
Indications, Safety, and Warnings MRI Safety Information

Description

For over a decade, the Endurant™ stent graft system has been chosen by physicians to treat more than half a million patients worldwide.1

As the first and only EVAR system with a decade of global registry outcomes, Endurant™ systems continue to prove durability and strength in evidence with consistently high sac regression and low aneurysm-related mortality (ARM).2

Choose the standard of EVAR durability.

Features

The Endurant™ system was designed with key features3 to address sac regression and ensure durability.4–6

Accurate placement and controlled deployment4

  • Intuitive graft deployment system7 offers controlled delivery at the intended target zone with 99.3% delivery and deployment success investigational device exemption (IDE).†,4​

  • Tip capture deployment mechanism — even after deployment of three stent rings — provides gradual, controlled, and accurate deployment at the intended sealing zone.4

Deployment of the Endurant™ II stent graft

Deployment of the Endurant™ IIs stent graft

Continuous seal5

  1. Separation of seal from fixation — with suprarenal fixation, which enables seal to occur independently.5
  2. M-shaped proximal stents, unique to the Endurant™ stent graft, maximize wall apposition and circumferential conformability5 to minimize in-folding resulting in low type Ia endoleak rates.2​
  3. Electropolished nitinol stents maximize circumferential conformability with dynamic continuous seal.5
The Endurant™ stent graft features a continuous seal.

Resistance against type II endoleak6

  • Woven, high-density, multifilament polyester material8 that promotes sac thrombosis6
  • Addresses sac regression3–6
The Endurant™ stent graft offers durability in aortic procedures.

Decade of durability data2​

Endurant™ AAA stent graft system: The first and only EVAR system with a decade of global registry outcomes.2

Explore Endurant™ clinical outcomes

The Endurant™ family of products

Three configurations

  • Bifurcated main body stent grafts:
    • Endurant™ II bifurcated configuration — an aortoiliac stent graft that is available in three lengths.
    • Endurant™ IIs bifurcated configuration — an aortic configuration available in a single, shorter length. 
  • Aorto-uni-iliac (AUI) main body stent graft:
    • The AUI device is indicated for the endovascular treatment of infrarenal abdominal aortic or aortoiliac aneurysms only in patients whose anatomy does not allow the use of a bifurcated device. The proximal end of the AUI configuration is deployed into the proximal neck and upper section of the aneurysm. The proximal section of the AUI configuration is composed of nitinol stents sewn to a fabric graft.
Endurant™ II stent graft is designed to treat abdominal aortic aneurysms (AAA) in both challenging and straightforward patient anatomy.

Endurant™ II stent graft

Endurant™ IIs stent graft is a three-piece system that is designed to treat abdominal aortic aneurysms (AAA) in both challenging and straightforward anatomy.

Endurant™ IIs stent graft

The Endurant™ II stent graft system aorto-uni-iliac (AUI) stent graft is indicated for the endovascular treatment of infrarenal abdominal aortic or aortoiliac aneurysms in patients whose anatomy does not allow the use of a bifurcated stent graft.

Endurant™ II AUI stent graft

Ordering information

Endurant™ II bifurcations

Item number Proximal graft diameter (mm) Distal graft diameter (mm) Distal design Total covered length (mm) Delivery system Catheter outer diameter (Fr)
ETBF2313C124E 23 13 C 124 E 18
ETBF2313C145E 23 13 C 145 E 18
ETBF2313C166E 23 13 C 166 E 18
ETBF2316C124E 23 16 C 124 E 18
ETBF2316C145E 23 16 C 145 E 18
ETBF2316C166E 23 16 C 166 E 18
ETBF2513C124E 25 13 C 124 E 18
ETBF2513C145E 25 13 C 145 E 18
ETBF2513C166E 25 13 C 166 E 18
ETBF2516C124E 25 16 C 124 E 18
ETBF2516C145E 25 16 C 145 E 18
ETBF2516C166E 25 16 C 166 E 18
ETBF2813C124E 28 13 C 124 E 18
ETBF2813C145E 28 13 C 145 E 18
ETBF2813C166E 28 13 C 166 E 18
ETBF2816C124E 28 16 C 124 E 18
ETBF2816C145E 28 16 C 145 E 18
ETBF2816C166E 28 16 C 166 E 18
ETBF2820C124E 28 20 C 124 E 18
ETBF2820C145E 28 20 C 145 E 18
ETBF2820C166E 28 20 C 166 E 18
ETBF3216C124E 32 16 C 124 E 20
ETBF3216C145E 32 16 C 145 E 20
ETBF3216C166E 32 16 C 166 E 20
ETBF3220C124E 32 20 C 124 E 20
ETBF3220C145E 32 20 C 145 E 20
ETBF3220C166E 32 20 C 166 E 20
ETBF3616C145E 36 16 C 145 E 20
ETBF3616C166E 36 16 C 166 E 20
ETBF3620C145E 36 20 C 145 E 20
ETBF3620C166E 36 20 C 166 E 20

Endurant™ IIs bifurcations

Item number Proximal graft diameter (mm) Distal graft diameter (mm) Distal design Total covered length (mm) Delivery system Catheter outer diameter (Fr)
ESBF2314C103E 23 14 C 103 E 18
ESBF2514C103E 25 14 C 103 E 18
ESBF2814C103E 28 14 C 103 E 18
ESBF3214C103E 32 14 C 103 E 20
ESBF3614C103E 36 14 C 103 E 20

Limbs‡

Item number Distal graft diameter (mm) Distal graft diameter (mm) Distal design Total covered length (mm) Delivery system Catheter outer diameter (Fr) Total contralateral covered length with EII/EIIs bifurcated§ Total ipsilateral covered length with EIIs bifurcated◊
ETLW1610C82E 16 10 C 82 E 14 132 152
ETLW1610C93E 16 10 C 93 E 14 143 163
ETLW1610C124E 16 10 C 124 E 14 174 174–194
ETLW1610C146E 16 10 C 146 E 16 196 196–216
ETLW1610C156E 16 10 C 156 E 16 206 206–226
ETLW1610C199E 16 10 C 199 E 16 249 249–269
ETLW1613C82E 16 13 C 82 E 14 132 152
ETLW1613C93E 16 13 C 93 E 14 143 163
ETLW1613C124E 16 13 C 124 E 14 174 174–194
ETLW1613C146E 16 13 C 146 E 16 196 196–216
ETLW1613C156E 16 13 C 156 E 16 206 206–226
ETLW1613C199E 16 13 C 199 E 16 249 249–269
ETLW1616C82E 16 16 C 82 E 14 132 132–152
ETLW1616C93E 16 16 C 93 E 14 143 143–163
ETLW1616C124E 16 16 C 124 E 14 174 174–194
ETLW1616C146E 16 16 C 146 E 16 196 196–216
ETLW1616C156E 16 16 C 156 E 16 206 206–226
ETLW1616C199E 16 16 C 199 E 16 249 249–269
ETLW1620C82E 16 20 C 82 E 16 132 152
ETLW1620C93E 16 20 C 93 E 16 143 163
ETLW1620C124E 16 20 C 124 E 16 174 174–194
ETLW1620C146E 16 20 C 146 E 16 196 196–216
ETLW1620C156E 16 20 C 156 E 16 206 206–226
ETLW1620C199E 16 20 C 199 E 16 249 249–269
ETLW1624C82E 16 24 C 82 E 16 132 152
ETLW1624C93E 16 24 C 93 E 16 143 163
ETLW1624C124E 16 24 C 124 E 16 174 174–194
ETLW1624C146E 16 24 C 146 E 16 196 196–216
ETLW1624C156E 16 24 C 156 E 16 206 206–226
ETLW1624C199E 16 24 C 199 E 16 249 249–269
ETLW1628C82E 16 28 C 82 E 16 132 152
ETLW1628C93E 16 28 C 93 E 16 143 163
ETLW1628C124E 16 28 C 124 E 16 174 174–194
ETLW1628C146E 16 28 C 146 E 16 196 196–216
ETLW1628C156E 16 28 C 156 E 16 206 206–226
ETLW1628C199E 16 28 C 199 E 16 249 249–269


‡ The limb mates with the AUI stent graft on the ipsilateral side.

§ These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant™ II/IIs stent graft system instructions for use.

◊ The 3–5 stent overlap is available only with select limbs. Please refer to the instructions for use for more information.

Aortic extensions

Item number Proximal graft diameter (mm) Distal graft diameter (mm) Distal design Total covered length (mm) Delivery system Catheter outer diameter (Fr)
ETCF2323C49E 23 23 C 49 E 18
ETCF2525C49E 25 25 C 49 E 18
ETCF2828C49E 28 28 C 49 E 18
ETCF3232C49E 32 32 C 49 E 20
ETCF3636C49E 36 36 C 49 E 20
ETTF2323C70E 23 23 C 70 E 18
ETTF2525C70E 25 25 C 70 E 18
ETTF2828C70E 28 28 C 70 E 18
ETTF3232C70E 32 32 C 70 E 20
ETTF3636C70E 36 36 C 70 E 20

AUI

Item number Proximal graft diameter (mm) Distal graft diameter (mm) Distal design Total covered length (mm) Delivery system Catheter outer diameter (Fr)
ETUF2314C102E 23 14 C 102 E 18
ETUF2514C102E 25 14 C 102 E 18
ETUF2814C102E 28 14 C 102 E 18
ETUF3214C102E 32 14 C 102 E 20
ETUF3614C102E 36 14 C 102 E 20

Iliac extensions

Item number Proximal graft diameter (mm) Distal graft diameter (mm) Distal design Total covered length (mm) Delivery system Catheter outer diameter (Fr)
ETEW1010C82E 10 10 C 82 E 14
ETEW1313C82E 13 13 C 82 E 14
ETEW2020C82E 20 20 C 82 E 16
ETEW2424C82E 24 24 C 82 E 16
ETEW2828C82E 28 28 C 82 E 18

Resources

Related links

Similar products

† Delivery success equals successful vascular access and delivery of the device to the intended anatomical treatment site. Deployment success equals successful deployment of the device in the intended site and the successful removal of the delivery system.

‡ The limb mates with the AUI stent graft on the ipsilateral side.

§ These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant™ II/IIs stent graft system instructions for use.

◊ The 3–5 stent overlap is available only with select limbs. Please refer to the instructions for use for more information.

  1. Based on internal Endurant™ patient implant tracking at Medtronic. Data current as of September 2023.
  2. Verhagen. The ENGAGE Registry: Ten-year outcomes with the Endurant stent graft for endovascular abdominal aortic aneurysm repair. Presented at: Charing Cross 2023 International Symposium; April 26, 2023; London, UK.

  1. Lalys F, Daoudal A, Gindre J, Göksu C, Lucas A, Kaladji A. Influencing factors of sac shrinkage after endovascular aneurysm repair. J Vasc Surg. 2017;65(6):1830–1838. doi:10.1016/j.jvs.2016.12.131.
  2. Makaroun MS, Tuchek M, Massop D, et al. One year outcomes of the United States regulatory trial of the Endurant stent graft system. J Vasc Surg. 2011;54(3):601–608. doi:10.1016/j.jvs.2011.03.002. 
  3. Based on internal test report DVR7245 design verification report: Endurant stent graft system™ conducted January–July 2007. 
  4. Wakefield TW, Shulkin BL, Fellows EP, Petry NA, Spaulding SA, Stanley JC. Platelet reactivity in human aortic grafts: a prospective, randomized midterm study of platelet adherence and release products in Dacron and polytetrafluoroethylene conduits. J Vasc Surg. 1989;9(2):234–243. doi:10.1067/mva.1989.vs0090234. 
  5. Rouwet EV, Torsello G, de Vries J-PPM, et al. Final results of the prospective European trial of the Endurant stent graft for endovascular abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2011;42(4):489–497. doi:10.1016/j.ejvs.2011.06.008.
  6. Based on internal materials report 10011927DOC Rev.AE.